Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age45+

SponsorAvisi Technologies Inc.

About this trial

A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial

Open angle, pseudoexfoliative or pigmentary glaucoma

IOP at preoperative visit of ≥ 20mmHg and ≤ 40mmHg

Visual field mean deviation score of -3dB or worse

Area of healthy, free and mobile conjunctiva in the target quadrant

Angle closure glaucoma

Congenital, neovascular or other secondary glaucomas

Previous intraocular surgery, with the exception of uncomplicated cataract surgery

Previous glaucoma shunt/valve in the target quadrant

165 Participants

are divided into 1 treatment group

Locations12

Select a site below to view it on the map.

South Africa

United States

Arizona

California

Colorado

Ohio

Pennsylvania

Texas

Wisconsin

Avisi Technologies Inc.

Lead sponsor